306 related articles for article (PubMed ID: 38540782)
1. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.
Bestari MB; Joewono IR; Syam AF
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540782
[TBL] [Abstract][Full Text] [Related]
2. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review.
Yang J; Xu R; Wang C; Qiu J; Ren B; You L
Cancer Commun (Lond); 2021 Dec; 41(12):1257-1274. PubMed ID: 34331845
[TBL] [Abstract][Full Text] [Related]
3. Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review.
Khan IA; Saraya A
J Gastrointest Cancer; 2023 Sep; 54(3):720-730. PubMed ID: 36322366
[TBL] [Abstract][Full Text] [Related]
4. New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer.
Yuan W; Tang W; Xie Y; Wang S; Chen Y; Qi J; Qiao Y; Ma J
Oncotarget; 2016 Nov; 7(48):80033-80045. PubMed ID: 27713117
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.
Zhu Y; Zhang H; Chen N; Hao J; Jin H; Ma X
Medicine (Baltimore); 2020 Jan; 99(3):e18581. PubMed ID: 32011436
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer.
Takai E; Yachida S
World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the Diagnostic Performance of Circulating MicroRNAs for Pancreatic Cancer.
Peng C; Wang J; Gao W; Huang L; Liu Y; Li X; Li Z; Yu X
Int J Med Sci; 2021; 18(3):660-671. PubMed ID: 33437201
[No Abstract] [Full Text] [Related]
8. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy in pancreatic cancer - Current perspective and future outlook.
Zhao Y; Tang J; Jiang K; Liu SY; Aicher A; Heeschen C
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188868. PubMed ID: 36842769
[TBL] [Abstract][Full Text] [Related]
10. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review.
Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
O'Neill RS; Stoita A
World J Gastroenterol; 2021 Jul; 27(26):4045-4087. PubMed ID: 34326612
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy techniques and pancreatic cancer: diagnosis, monitoring, and evaluation.
Wang K; Wang X; Pan Q; Zhao B
Mol Cancer; 2023 Oct; 22(1):167. PubMed ID: 37803304
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer.
Lee B; Lipton L; Cohen J; Tie J; Javed AA; Li L; Goldstein D; Burge M; Cooray P; Nagrial A; Tebbutt NC; Thomson B; Nikfarjam M; Harris M; Haydon A; Lawrence B; Tai DWM; Simons K; Lennon AM; Wolfgang CL; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
Ann Oncol; 2019 Sep; 30(9):1472-1478. PubMed ID: 31250894
[TBL] [Abstract][Full Text] [Related]
14. Upregulated exosomic miR‑23b‑3p plays regulatory roles in the progression of pancreatic cancer.
Chen D; Wu X; Xia M; Wu F; Ding J; Jiao Y; Zhan Q; An F
Oncol Rep; 2017 Oct; 38(4):2182-2188. PubMed ID: 28849236
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer.
Gao Y; Zhu Y; Yuan Z
Int J Med Sci; 2016; 13(12):902-913. PubMed ID: 27994495
[TBL] [Abstract][Full Text] [Related]
16. Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer.
Hussein NA; Kholy ZA; Anwar MM; Ahmad MA; Ahmad SM
J Cancer Res Clin Oncol; 2017 Jan; 143(1):83-93. PubMed ID: 27631726
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in ovarian cancer.
Giannopoulou L; Lianidou ES
Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
[TBL] [Abstract][Full Text] [Related]
18. Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.
Wei L; Yao K; Gan S; Suo Z
Medicine (Baltimore); 2018 Aug; 97(35):e12132. PubMed ID: 30170450
[TBL] [Abstract][Full Text] [Related]
19. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R
J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585
[TBL] [Abstract][Full Text] [Related]
20. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
